Role of 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Parkinsonian Disorders
Masahiko Suzuki · InTech eBooks · 2012
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
InTech eBooks · OpenAlex · book-chapter · 2012
Abstract
emerged as a useful method to confirm or exclude the presence of PD (Jost et al., 2010).Thus, 123 I-MIBG scintigraphy is the only method that can distinguish with a high degree of sensitivity and specificity between parkinsonian disorders and PD.In the present study, we evaluated 123 I-MIBG myocardial scintigraphy in patients with PD, DLB, AR-JP, and MSA in order to enhance the differentiation of PD from these other neurological diseases that mimic PD.
Material and methods PatientsA total of 74 subjects were enrolled prospectively based on the criteria outlined below for PD (n = 36), DLB (n = 6), MSA (n = 14), AR-JP (n = 2), and normal control groups (NC; n = 16).There was no significant difference in age between patients with parkinsonism and NC (P = 0.25), and none of the enrolled subjects had clinical evidence of diabetes mellitus or cardiovascular disease.Cases were excluded if no relevant clinical information was provided.In addition, none of the participating subjects were taking drugs that might interfere with 123 I-MIBG uptake (Solanki et al., 1992; Wafelman et al., 1994;Braune et al., 2001).The diagnosis of probable DLB was made based on the criteria of DLB adopted by the International National Workshop on DLB (McKeith et al., 1996).Six patients with DLB had early recurrent visual hallucinations and delusions unrelated to therapy, marked fluctuations in alertness, progressive cognitive decline, and spontaneous motor features of parkinsonism.These psychiatric symptoms became worse with administration of anticholinergic agents and dopamine agonists.Thirty-six patients with idiopathic PD (Hoehn and Yahr (HY) stage 1, 8 patients; HY 2, 22 patients; HY 3, 6 patients) showed two or more of the following cardinal features of PD: rest tremor, bradykinesia, muscular rigidity, loss of postural reflexes, and unilateral symptoms; thus fulfilling standard diagnostic criteria 6.All PD patients had a good or excellent initial response to levodopa treatment.Fourteen patients presented with probable MSA according to the criteria reported by Gilman and colleagues (Gilman et al., 1999); all showed extrapyramidal symptoms and corticospinal dysfunction, sporadic adult-onset, and rapid disease progression without dementia.These patients tended to be unresponsive to levodopa or dopamine agonist therapy.The study included two patients with AR-JP.Both had consanguineous parents and were only first generation.Their clinical features included early-onset (in the 20s) and levodoparesponsive parkinsonism, diurnal fluctuation, and slow progression of the disease.The disease presented initially with dystonic posture of the legs followed by a gradual development of parkinsonism.Their parkinsonian symptoms were responsive to levodopa, although a gradual decline in the efficacy was noted.The parkinsonian triad was mild, and the tremor was usually fine and postural.The levodopa efficacy was sufficient and the clinical course was benign; however, both showed a clear wearing-off phenomenon.
How to referenceIn order to correctly reference this scholarly work, feel free to copy and paste the following: Masahiko Suzuki (2012).Role of 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Parkinsonian Disorders, Mechanisms in Parkinson's Disease -Models and Treatments, Dr. Juliana Dushanova (Ed.), ISBN: 978-953-307-876-2, InTech, Available from: http://www.intechopen.com/books/mechanisms-in-parkinson-s-disease-models-and-treatments/the-role-of
Open the resolved locator · 10.5772/17517
Metadata licence: OpenAlex metadata (CC0)